Logotype for GMO Financial Holdings Inc

GMO Financial Holdings (7177) Q3 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for GMO Financial Holdings Inc

Q3 2024 earnings summary

15 May, 2026

Executive summary

  • Achieved record-high operating revenue for Q3 YTD at ¥40,420 million (+5.4% YoY), but profit declined due to a ¥6,700 million loan loss provision in the Thai securities business.

  • Net operating revenue for Q3 YTD was ¥37,354 million (+4.0% YoY), with net income dropping 46.3% YoY to ¥3,509 million.

  • Q3 (July–September) saw a significant profit rebound sequentially as loan loss provisions decreased from the previous quarter.

  • The Thailand securities business will end margin trading services as of December 20, 2024, with potential for further provisions if collateral values decline.

Financial highlights

  • Operating revenue for Q3 YTD: ¥40,420 million (+5.4% YoY); net operating revenue: ¥37,354 million (+4.0% YoY).

  • Operating income for Q3 YTD: ¥8,679 million (−23.8% YoY); ordinary income: ¥7,978 million (−28.7% YoY); net income: ¥3,509 million (−46.3% YoY).

  • Q3 (July–September) operating income: ¥3,734 million, up 530.3% from Q2.

  • Total assets: ¥1,156,908 million (+¥31,409 million from previous year-end); net assets: ¥48,289 million (+¥1,848 million).

  • EPS: ¥29.74 (basic) for the period.

Outlook and guidance

  • Aims to complete loss processing for the Thai securities business within FY2024 and is considering withdrawal to minimize future loss risk.

  • No consolidated earnings forecast disclosed due to high sensitivity to economic and market conditions in securities, FX, and crypto asset businesses.

  • Key monthly business indicators such as FX trading volume, stock brokerage commissions, CFD trading, and crypto asset trading are disclosed instead.

  • FY2024 dividend payout ratio target is 50%+ with quarterly dividends.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more